Effectiveness of structured physiotherapy in constipation in children with neurodevelopmental disorders-a randomized

Sayali Joshi1, Sanjay Parmar1, Akshay Kalavant2

  • 1SDM College of Physiotherapy, SDM University, Dharwad, India.

Insights

Structured physiotherapy significantly improved constipation and quality of life in children with neurodevelopmental disorders (NDD), outperforming conventional therapy alone.

Area of Science:

  • Pediatrics
  • Neurodevelopmental Disorders
  • Gastroenterology

Background:

  • Constipation is a prevalent issue in children with neurodevelopmental disorders (NDD).
  • Current treatments for NDD-related constipation have varying degrees of effectiveness.

Purpose of the Study:

  • To evaluate the effectiveness of a structured physiotherapy program for constipation in children with NDD.
  • To compare the combined effect of structured and conventional physiotherapy versus conventional physiotherapy alone.

Main Methods:

  • A randomized controlled trial involving 35 children with NDD, with 22 completing a 2-week intervention.
  • Children were divided into two groups: conventional physiotherapy (Group A) and conventional plus structured physiotherapy (Group B).
  • Outcomes measured included the Pediatric Quality of Life Inventory (PedsQL), PedsQL Gastrointestinal Symptoms Scale, Bristol Stool Form Scale, and defecation frequency.

Main Results:

  • Group A showed no significant improvements.
  • Group B demonstrated statistically significant improvements in all measured outcomes.
  • Significant changes were observed in PedsQL GI symptoms scale (p=0.045), its constipation sub-scale (p=0.002), and Bristol stool form in Group B.

Conclusions:

  • The combination of structured and conventional physiotherapy is more effective than conventional physiotherapy alone for managing constipation in children with NDD.
  • This combined approach improves stool form, constipation symptoms, and related quality of life factors.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
311
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
283
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
301
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
534
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
284
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
229